PPT-BUPE: Buprenorphine Understanding in the Pharmacy Environment

Trish Mashburn PharmD April 7th 2022 Course Information Presentation is sponsored by the North Carolina Association of Pharmacists NCAP  This live course has been adapted from the following online training module . Kylie Reed . a,b. ,. Karolina . Bogdanowicz. . b, . James Bell . a,b. , . Rob . VanderWaal. . a, . Jenny Keen . a,b. , . Pete . Beavan. . a. , Shelagh Baillie . c, . Alastair Knight . d, . John . Cindy Puffer RPh . Managed Care Pharmacy Operations Manager . Pharmacy Services . May 29, 2014 . Outline the Evolution of Drug Benefit Management. Understanding Pharmacy Benefit Management (PBM) pricing. HMI Public Hearing. Set 1 Hearing 2. Pharmaceutical Society of South Africa. Overview. Regulatory framework. Healthcare funding. Imperfect information and understanding. Barriers to entry and expansion. Treatment (MAT):. Problem . or Solution?. Quintin Thomas Chipley, M.A., M.D., Ph.D.. a. nd. Greg Jones, M.D., ABFM, ABAM, MRO. Prepared for CAPTASA 2016. DISCLOSURES. Neither presenter has any financial interest in any mode of treatment as discussed in this presentation.. What is Bupe? Buprenorphine (often referred to as “Bupe”) is a prescription drug made under the brand names of Suboxone and Subutex in prescription pain pills like oxycodone and hydrocodone that BUPRENORPHINE upport with problem drug use www.colorado.gov/ladders Reprinted and/or reproduced with permission from the New CAN I SWITCH FROM METHADONE TO BUPE?Yes, but talk to you doctor rst BUPRENORPHINE For support with problem drug use and for other resources: Talk to your doctor nyc.gov/health CAN I SWITCH FROM METHADONE TO BUPE?Yes, but talk to you doctor rst to make sure you ar Therapy. Opioids. and HIV. You may know that…. Injection drug use (IDU), either directly or via sexual contact with an IDU partner, accounts for one-third of the cumulative estimated AIDS cases in the U.S.. Haley Pals, PharmD, BCPP. Tomah VA Medical Center, Tomah WI. ECHO January 6. th. , 2022. Objectives . Recognize the possible routes of training for pharmacists. Identify various established buprenorphine collaborations. Patient Assessmen • Establishment of a diagnosis of Opioid Use Disorder (OUD). • Discussion of current opioid use. • Evaluation of patient’s readiness to participate. • Ph BUPRENORPHINE NALOXONE BNM Sublingual Tablets Buprenorphine Hydrochloride Naloxone Hydrochloride Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you are Isaac Marsolek MD. Procedural sedation and . Bupe. How should patients be managed?. Difference for procedures with local anesthetic vs without local anesthetic?. Disclaimer. Isaac Marsolek. What is the issue?. Tim Furnish, MD. Clinical Professor. UC San Diego Health. August . 2023. Disclosures. Fellowship Educational Grants: . Medtronic, Abbott, Boston Scientific, Nevro. Buprenorphine. Buprenorphine. FDA Indications, uses, and legal distinctions. Microdosing. . NORTHERN COLORADO MAT LEARNING FORUM. Lesley Brooks, MD. Thursday, April 4, 2019. To Review…. . Bupe. induction and maintenance checklist. Need for withdrawal prior to induction.